Table 1.
Baseline data and laboratory indicators of the participants.
| Variables | Control (n = 59) | AMI (n = 156) | P value | |
|---|---|---|---|---|
| Gender | Male | 25 | 77 | 0.360 |
| Female | 34 | 79 | ||
| Age (year) | 51.00 (9.00) | 52.00 (11.00) | 0.119 | |
| BMI (kg/m2) | 23.72 (4.57) | 23.05 (4.84) | 0.214 | |
| Smoking history | 15 | 37 | 0.794 | |
| Hypertension | 11 | 36 | 0.483 | |
| Diabetes | 8 | 19 | 0.785 | |
| TC (mmol/L) | 4.08 (1.28) | 3.87 (1.10) | 0.316 | |
| TG (mmol/L) | 0.87 (0.37) | 0.90 (0.34) | 0.445 | |
| HDL-C (mmol/L) | 1.66 (0.55) | 1.61 (0.40) | 0.553 | |
| LDL-C (mmol/L) | 2.34 (0.89) | 2.51 (0.95) | 0.379 | |
| Myo (ng/mL) | 58.53 (6.30) | 87.17 (10.41) | <0.001 | |
| cTnI (µg/L) | 0.45 (0.18) | 1.72 (0.41) | <0.001 | |
| LVEF (%) | 63.23 (6.73) | 51.88 (9.58) | <0.001 | |
| CK-MB (ng/mL) | 2.92 (0.87) | 12.22 (1.29) | <0.001 | |
BMI, body mass index; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; Myo, myoglobin; cTnI, cardiac troponin I; CARMN, cardiac mesoderm enhancer-associated non-coding RNA; LVEF, left ventricular ejection fraction; CK-MB, creatine kinase-myocardial band.